老年患者愿意少服用2型糖尿病的药物:糖尿病与衰老研究
Shanzay Haider1,2, Melissa M Parker3, Elbert S Huang4
1Section of Endocrinology, Department of Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
患有糖尿病的老年人愿意减少药物治疗,但糖尿病持续时间较长或年龄较大的人不那么愿意. 这挑战了对老年患者的治疗减强指南.
科学领域:
- 老年学是一门学科.
- 内分泌学 在内分泌学.
- 临床药房 临床药房
背景情况:
- 患有糖尿病的老年人往往有复杂的药物治疗方案.
- 治疗减强旨在减少该群体的药物负担和相关风险.
- 了解患者的意愿对于成功的减强策略至关重要.
研究的目的:
- 评估患有糖尿病的老年人是否愿意减少服用降血糖药物的意愿.
- 识别患者的特征与愿意减轻糖尿病治疗的意愿相关.
主要方法:
- 对1337名患有糖尿病的老年人 (65-100岁) 进行了一项调查.
- 参与者从凯泽永久北加利福尼亚州糖尿病登记处抽取样本.
- 降低强度的意愿被分类,并分析了与临床因素的关联.
主要成果:
- 超过51%的老年人愿意减少服用糖尿病药物.
- 随着年龄的增长 (85岁以上) 和糖尿病持续时间的延长 (15岁以上),意愿性下降.
- 服用较少药物的患者 (1-2) 比服用多种药物的患者 (10+) 更愿意降低强度.
结论:
- 尽管指导方针建议长期糖尿病的老年患者减强治疗,但这些人表现出不太愿意.
- 患者减少药物的意愿受年龄和糖尿病持续时间的影响.
- 需要进一步的研究,以使临床建议与患者对糖尿病治疗减强的偏好保持一致.
更多相关视频
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
05:06Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
Published on: July 14, 2023
相关概念视频
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Diabetes Mellitus: Type 2 and Gestational
Factors Affecting Drug Response: Overview
